Quick Answer
VSEE HEALTH, INC. reported Total Revenue of $14.62 million for fiscal year 2025.
VSEE HEALTH, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $14.62M +40.3% |
$10.42M +80.7% |
$5.77M | — | — |
| Revenue (ASC 606) | $14.62M +40.3% |
$10.42M +80.7% |
$5.77M | — | — |
| Net Income | — | -$57.70M -1433.4% |
-$3.76M -16.1% |
-$3.24M | — |
| Diluted EPS | -$0.73 +87.1% |
-$5.65 -1386.8% |
-$0.38 -52.0% |
-$0.25 | — |
| Total Assets | $22.41M -71.5% |
$78.59M +9652.9% |
$805.8K -89.4% |
$7.63M -93.5% |
$117.94M |
| Cash and Equivalents | $5.27M +1514.9% |
$326.1K +174.7% |
$118.7K +11.0% |
$107.0K -85.9% |
$760.0K |
| Long-Term Debt | $593.9K +0.0% |
$593.9K | — | — | — |
| Stockholders Equity | $5.45M +229.7% |
-$4.20M -281.4% |
-$1.10M +85.2% |
-$7.43M | $0.00 |
| Operating Income | -$9.58M +84.6% |
-$62.15M -3217.2% |
-$1.87M +47.9% |
-$3.59M | — |
| Gross Profit | $7.36M +2.5% |
$7.18M +87.3% |
$3.83M | — | — |
| Shares Outstanding | 33.19M +125.9% |
14.69M +216.7% |
4.64M +11.6% |
4.16M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $3.98M | +18.7% | +17.4% |
| Revenue (ASC 606) | September 30, 2025 | $3.98M | +18.7% | +17.4% |
| Net Income | June 30, 2025 | -$2.61M | -312.1% | +34.0% |
| Diluted EPS | September 30, 2025 | -$0.02 | +99.4% | +87.5% |
| Total Assets | September 30, 2025 | $18.71M | -16.1% | +2.7% |
| Cash and Equivalents | September 30, 2025 | $472.8K | -79.7% | +62.1% |
| Long-Term Debt | September 30, 2025 | $589.4K | -0.8% | -0.8% |
| Stockholders Equity | September 30, 2025 | -$5.58M | -697.5% | +2.8% |
| Operating Income | September 30, 2025 | -$2.06M | +96.5% | +8.7% |
| Gross Profit | September 30, 2025 | $2.07M | -25.5% | +30.5% |
| Shares Outstanding | September 30, 2025 | 17.02M | +10.8% | +3.7% |
- VSEE HEALTH, INC. reported Total Revenue of $14.62 million for fiscal year 2025.
- VSEE HEALTH, INC. showed an increase of +40.3% in Total Revenue compared to the prior fiscal year.
- VSEE HEALTH, INC. reported Revenue (ASC 606) of $14.62 million for fiscal year 2025.
- VSEE HEALTH, INC. showed an increase of +40.3% in Revenue (ASC 606) compared to the prior fiscal year.
- VSEE HEALTH, INC. reported Net Income of -$57.70 million for fiscal year 2024.
- VSEE HEALTH, INC. showed a decrease of -1433.4% in Net Income compared to the prior fiscal year.
- VSEE HEALTH, INC. reported Diluted EPS of $0.73 per share (loss) for fiscal year 2025.
- VSEE HEALTH, INC. showed an increase of +87.1% in Diluted EPS compared to the prior fiscal year.
- VSEE HEALTH, INC. reported Total Assets of $22.41 million for fiscal year 2025.
- VSEE HEALTH, INC. showed an increase of +12.1% in Total Assets compared to the prior fiscal year.
- VSEE HEALTH, INC. reported Cash and Equivalents of $5.27 million for fiscal year 2025.
- VSEE HEALTH, INC. showed an increase of +1514.9% in Cash and Equivalents compared to the prior fiscal year.
- VSEE HEALTH, INC. reported Long-Term Debt of $593.9 thousand for fiscal year 2025.
- VSEE HEALTH, INC. showed an increase of +0.0% in Long-Term Debt compared to the prior fiscal year.
- VSEE HEALTH, INC. reported Stockholders Equity of $5.45 million for fiscal year 2025.
- VSEE HEALTH, INC. showed an increase of +29591.4% in Stockholders Equity compared to the prior fiscal year.
- VSEE HEALTH, INC. reported Operating Income of -$9.58 million for fiscal year 2025.
- VSEE HEALTH, INC. showed an increase of +84.6% in Operating Income compared to the prior fiscal year.
- VSEE HEALTH, INC. reported Gross Profit of $7.36 million for fiscal year 2025.
- VSEE HEALTH, INC. showed an increase of +2.5% in Gross Profit compared to the prior fiscal year.
- VSEE HEALTH, INC. reported Shares Outstanding of 33.19 million shares for fiscal year 2025.
- VSEE HEALTH, INC. showed an increase of +103.7% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: